30.10.2024 07:00 | AVCT | R&D Spotlight focusing on pipeline advances | RNS |
28.10.2024 07:00 | AVCT | Block Listing Six Monthly Return | RNS |
24.10.2024 07:00 | AVCT | Avacta Reports Pipeline Avances at EORTC | RNS |
21.10.2024 16:00 | AVCT | Issue of Equity and Total Voting Rights | RNS |
21.10.2024 14:31 | AVCT | Avacta partners with Tempus to enable AI-driven drug development | Alliance |
17.10.2024 13:39 | AVCT | Avacta expands pipeline with two novel preclinical assets | Alliance |
17.10.2024 07:00 | AVCT | Avacta Expands its Pipeline | RNS |
15.10.2024 11:18 | PHSC, AVCT, DELT | EXECUTIVE CHANGES: PHSC co-founder and Deltic Energy CEO depart | Alliance |
15.10.2024 07:00 | AVCT | Avacta appoints Chief Scientific Officer | RNS |
10.10.2024 07:00 | AVCT | Avacta Unveils Pipeline Expansion at EORTC 2024 | RNS |
30.09.2024 13:14 | MTEC, TBLD, PIER | EARNINGS: Brighton Pier gives downbeat outlook; Seeen "has momentum" | Alliance |
30.09.2024 07:00 | AVCT | Interim Results | RNS |
23.09.2024 14:12 | XSG, SPSY, TBLD | UK earnings, trading statements calendar - next 7 days | Alliance |
17.09.2024 10:57 | NFG, AVCT, WSBN | AIM WINNERS & LOSERS: Warpaint paints confident picture; Next 15 down | Alliance |
17.09.2024 09:50 | THG, LTG, AVCT | LONDON BROKER RATINGS: Berenberg, Peel cut TT Electronics to 'hold' | Alliance |
16.09.2024 07:00 | AVCT | Avacta Reported Updated Phase 1 Data of AVA6000 | RNS |
12.09.2024 07:00 | AVCT | Notice of Results | RNS |
09.09.2024 07:00 | AVCT | Avacta to present clinical data at ESMO Congress | RNS |
02.09.2024 15:53 | AVCT | Director/PDMR Shareholdings and TVR | RNS |
18.07.2024 07:00 | AVCT | Convertible Bond Payment | RNS |
26.06.2024 19:25 | AVCT, THX, SVML | TRADING UPDATES: Sovereign Metals signs deal with Palladium Group | Alliance |
26.06.2024 14:46 | AVCT | Result of AGM | RNS |
26.06.2024 07:00 | AVCT | AGM Business Update | RNS |
20.06.2024 07:00 | AVCT | Shaun Chilton appointed Non-Executive Chairman | RNS |
19.06.2024 12:56 | W7L, SAL, RAI | UK shareholder meetings calendar - next 7 days | Alliance |
19.06.2024 09:43 | WISE, AVCT, TEP | LONDON BROKER RATINGS: Deutsche Bank likes Vodafone and raises Avacta | Alliance |
11.06.2024 07:00 | AVCT | Appointment of Nominated Adviser and Sole Broker | RNS |
31.05.2024 07:00 | AVCT | Posting of Annual Report and Notice of AGM | RNS |
23.05.2024 21:25 | PXC, AVCT, PALM | TRADING UPDATES: Windward wins deal; Kodal progresses at Bougouni | Alliance |
23.05.2024 07:00 | AVCT | Successful Completion of First Cohort | RNS |
07.05.2024 09:51 | AIBG, BIRG, S32 | LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered | Alliance |
01.05.2024 11:53 | AVCT | IN BRIEF: Avacta picks Christina Coughlin to replace long-serving CEO | Alliance |
30.04.2024 16:30 | CODE, KLSO, S247 | EARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV down | Alliance |
30.04.2024 07:01 | AVCT | Full Year Results | RNS |
30.04.2024 07:00 | AVCT | Board Change | RNS |
26.04.2024 09:51 | AVCT | Block listing Interim Return REPLACEMENT | RNS |
26.04.2024 07:00 | AVCT | Block Listing Six Monthly Return | RNS |
23.04.2024 14:26 | WTB, ROR, SAFE | UK earnings, trading statements calendar - next 7 days | Alliance |
23.04.2024 09:43 | AVCT | Block Listing Application to AIM | RNS |
23.04.2024 07:00 | AVCT | Notice of Results | RNS |
22.04.2024 17:51 | 1SN, AVCT, ZEN | TRADING UPDATES: First Tin updates Tellerhauser estimates | Alliance |
22.04.2024 12:14 | AVCT | Issue of Equity and Total Voting Rights | RNS |
09.04.2024 17:00 | AVCT | Avacta Reports Data at the AACR Annual Meeting | RNS |
08.04.2024 07:00 | AVCT | AVA6000 Abstract Release by AACR | RNS |
28.03.2024 16:00 | AVCT | Investor Webinar | Reach |
21.03.2024 10:37 | AVCT | Avacta doses third patient in drug conjugate trial for tumour tissue | Alliance |
21.03.2024 07:00 | AVCT | Update on AVA6000 Phase 1a Clinical Trial Progress | RNS |
18.03.2024 14:31 | AVCT | IN BRIEF: Avacta shareholders give AGM go-ahead to issue new shares | Alliance |
18.03.2024 13:26 | AVCT | Result of General Meeting | RNS |
06.03.2024 07:00 | AVCT | Avacta Announces AVA6000 Poster at AACR | RNS |
05.03.2024 17:09 | ARB, AVCT, STVG | EARNINGS AND TRADING: Harland & Wolff wins major Falklands contract | Alliance |
05.03.2024 07:00 | AVCT | Result of REX Retail Offer | RNS |
29.02.2024 12:18 | AVCT | Avacta increases placing size to GBP26 million thanks to strong demand | Alliance |
29.02.2024 10:27 | AVCT, BCE, THR | AIM WINNERS & LOSERS: Beacon Energy and Avacta fall on fundraise | Alliance |
29.02.2024 07:00 | AVCT | Result of Placing | RNS |
28.02.2024 20:31 | CGO, BCE, DSM | TRADING UPDATES: Avacta plans fundraise to fund clinical development | Alliance |
28.02.2024 16:42 | AVCT | Proposed REX Retail Offer | RNS |
28.02.2024 16:41 | AVCT | Proposed Fundraise to progress Therapeutics | RNS |
16.02.2024 07:00 | AVCT | Share Incentive Plan/Issue of Equity | RNS |
22.01.2024 10:51 | AVCT | Issue of Equity and Total Voting Rights | RNS |
19.01.2024 09:11 | AVCT | IN BRIEF: Avacta says new head of R&D Coughlin brings "deep expertise" | Alliance |
19.01.2024 07:00 | AVCT | Appointment of Christina Coughlin | RNS |
19.12.2023 09:57 | AVCT | IN BRIEF: Avacta taps biopharma veteran as Therapeutics business chief | Alliance |
19.12.2023 07:00 | AVCT | Appointment of Chief Business Officer | RNS |
13.12.2023 11:49 | AVCT | Avacta says study shows cancer treatment AVA6000 working as planned | Alliance |
13.12.2023 07:00 | AVCT | ALS-6000-101 Phase 1a Study Data | RNS |
04.12.2023 07:00 | AVCT | Shareholder update to review AVA6000 Phase 1a data | RNS |
27.10.2023 07:00 | AVCT | Block Listing Six Monthly Return | RNS |
23.10.2023 13:30 | AVCT | Issue of Equity and Total Voting Rights | RNS |
18.10.2023 13:00 | AVCT | Block Listing Application to AIM | RNS |
29.09.2023 13:30 | AVCT | Director/PDMR Shareholding | RNS |
28.09.2023 11:08 | AVCT | IN BRIEF: Avacta loss widens on cost rise but clinical tests positive | Alliance |
28.09.2023 07:00 | AVCT | Interim Results for the Period Ending 30 June 2023 | RNS |
21.09.2023 15:48 | XLM, TRLS, SBDS | UK earnings, trading statements calendar - next 7 days | Alliance |
20.09.2023 14:37 | GENF, UJO, AVCT | TRADING UPDATES: Capital inks contract; Lansdowne becomes cash shell | Alliance |